SERA 6.54 (+7.04%)
US81749D1072• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. SERA

Sera Prognostics (SERA) Competitor Comparison

We are evaluating the key criteria listed to compare Sera Prognostics (SERA) against its competitors in the Diagnostics & Research industry.

Market Capitalization

39 / 58

Gross Profits

51 / 52

Total Revenue

54 / 57

EBITDA

43 / 56

Free Cashflow

41 / 56

Quick Ratio

21 / 57

Earnings per Share

33 / 56

Dividend yield

0 / 9

Total Cash

40 / 57

Performance 3 years

25 / 58

Performance 5 years

39 / 58

Performance 10 years

38 / 58

Linearity 3 years

27 / 58

Linearity 5 years

36 / 58

Linearity 10 years

21 / 58

Total Rank

49 / 58

Dividend Rank

33 / 58

Valuation Rank

46 / 58

Piotroski Rank

45 / 58

Muliplier Rank

33 / 58

Linearity 3 years - SERA ranking 27 / 58

These are the competitors of Sera Prognostics in the industry Diagnostics & Research ranked by linearity 3 years
1. Laboratory Corp of America Holdings LH
49.35
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. Quest Diagnostics DGX
31.51
4. Waters WAT
17.05
5. PerkinElmer PKI
16.14
6. Agilent Technologies A
15.76
7. Bioventus BVS
14.27
8. Syneos Health SYNH
10.68
9. Mettler-Toledo MTD
10.61
10. Danaher DHR
10.35
11. Thermo Fisher Scientific TMO
9.92
12. Icon ICLR
9.79
13. Anixa Biosciences ANIX
8.88
14. IQVIA Holdings IQV
8.39
15. Heska HSKA
7.67
16. Qiagen QGEN
7.46
17. Olink Holding OLK
6.67
18. IDEXX Laboratories IDXX
6
19. Exact Sciences EXAS
4.86
20. Myriad Genetics MYGN
4.79
21. National Research NRC
4.43
22. Sotera Health SHC
4.41
23. Global Cord Blood CO
4.22
24. DexCom DXCM
4.06
25. Charles River Laboratories CRL
3.58
26. Medpace Holdings MEDP
2.97
27. Sera Prognostics SERA
2.88
28. CareDx CDNA
2.87
29. Illumina ILMN
2.74
30. MaxCyte MXCT
2.61
31. Enzo Biochem ENZ
2.57
32. Neogen NEOG
2.55
33. Psychemedics PMD
2.55
34. NeoGenomics NEO
2.42
35. MDxHealth MDXH
2.36
36. Twist Bioscience TWST
2.35
37. Trinity Biotech TRIB
2.11
38. Exagen XGN
2.05
39. Guardant Health GH
2.02
40. Neuronetics STIM
1.98
41. Interpace Biosciences IDXG
1.97
42. Fulgent Genetics FLGT
1.94
43. Precipio PRPO
1.86
44. DarioHealth DRIO
1.79
45. Organovo Holdings ONVO
1.79
46. Pacific Biosciences of California PACB
1.73
47. Personalis PSNL
1.72
48. Biodesix BDSX
1.69
49. bioAffinity Technologies BIAF
1.69
50. Co-Diagnostics CODX
1.67
51. Prenetics Global PRE
1.64
52. SeqLL SQL
1.48
53. Inotiv NOTV
1.41
54. Aspira Womens Health AWH
1.38
55. Lantheus Holdings LNTH
1.38
56. Natera NTRA
0.86
57. Meridian Bioscience VIVO
0.73
58. RadNet RDNT
0.31
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.